FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129404964> ?p ?o ?g. }

• W2129404964 endingPage "210" @default.
• W2129404964 startingPage "203" @default.
• W2129404964 abstract "Increased fat mass contributes to bone deterioration. Glucagon-like peptide 1 (GLP-1) and its related peptide exendin 1-39 amide (Ex-4), two lipid-lowering peptides, exert osteogenic effects in diabetic states. We examined the actions of 3-day administration of GLP-1 or Ex-4 on bone remodeling markers and on bone mass and structure in hyperlipidic (HL) and hypercaloric rats. Wistar rats on a hyperlipidemic diet for 35 days were subcutaneously administered GLP-1 (0.86 nmol/kg per h), Ex-4 (0.1 nmol/kg per h), or saline (control) by continuous infusion for 3 days. After killing, tibiae were removed for total RNA and protein isolation, as well as femurs and L1-L4 vertebrae for bone mass and quality assessment. Body weight and plasma insulin were unaltered in HL rats, which showed osteopenia (by dual-energy X-ray absorptiometry), associated with hyperglycemia, hypertriglyceridemia, and hypercholesterolemia. GLP-1 or Ex-4 administration decreased the levels of glucose, triglycerides, and total cholesterol in plasma but increased osteocalcin (OC) gene expression and the osteoprotegerin (OPG)/receptor activator of NF-κB ligand (RANKL) ratio - at the expense of an augmented OPG - above corresponding control values in the tibia. Each tested peptide similarly reversed the decreased femoral and vertebral bone mass in these rats, whereas the deteriorated trabecular structure in the vertebrae improved associated with normalization of bone remodeling. These findings demonstrate that GLP-1 and Ex-4 are similarly efficient in reversing the bone alterations in this HL rat model, which has proven to be useful for studying the fat-bone relationships." @default.
• W2129404964 created "2016-06-24" @default.
• W2129404964 creator A5005643972 @default.
• W2129404964 creator A5015843988 @default.
• W2129404964 creator A5023620537 @default.
• W2129404964 creator A5050027407 @default.
• W2129404964 creator A5065683911 @default.
• W2129404964 creator A5066301296 @default.
• W2129404964 creator A5069514816 @default.
• W2129404964 date "2011-03-03" @default.
• W2129404964 modified "2023-10-18" @default.
• W2129404964 title "GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia" @default.
• W2129404964 cites W1507814807 @default.
• W2129404964 cites W1969759659 @default.
• W2129404964 cites W1974995152 @default.
• W2129404964 cites W1980740451 @default.
• W2129404964 cites W1983901940 @default.
• W2129404964 cites W1987176983 @default.
• W2129404964 cites W1987621836 @default.
• W2129404964 cites W2001197467 @default.
• W2129404964 cites W2003298815 @default.
• W2129404964 cites W2004092276 @default.
• W2129404964 cites W2009315141 @default.
• W2129404964 cites W2010308446 @default.
• W2129404964 cites W2021022471 @default.
• W2129404964 cites W2026670401 @default.
• W2129404964 cites W2029102093 @default.
• W2129404964 cites W2031055048 @default.
• W2129404964 cites W2036678616 @default.
• W2129404964 cites W2037910337 @default.
• W2129404964 cites W2046111383 @default.
• W2129404964 cites W2047511843 @default.
• W2129404964 cites W2060817141 @default.
• W2129404964 cites W2064367148 @default.
• W2129404964 cites W2070710390 @default.
• W2129404964 cites W2071866278 @default.
• W2129404964 cites W2073614541 @default.
• W2129404964 cites W2087378917 @default.
• W2129404964 cites W2089329935 @default.
• W2129404964 cites W2099903872 @default.
• W2129404964 cites W2107794104 @default.
• W2129404964 cites W2112715095 @default.
• W2129404964 cites W2114913346 @default.
• W2129404964 cites W2122711688 @default.
• W2129404964 cites W2162669241 @default.
• W2129404964 cites W2167984392 @default.
• W2129404964 cites W2172263534 @default.
• W2129404964 cites W2248623090 @default.
• W2129404964 cites W3203441888 @default.
• W2129404964 doi "https://doi.org/10.1530/joe-11-0015" @default.
• W2129404964 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21372151" @default.
• W2129404964 hasPublicationYear "2011" @default.
• W2129404964 type Work @default.
• W2129404964 sameAs 2129404964 @default.
• W2129404964 citedByCount "72" @default.
• W2129404964 countsByYear W21294049642012 @default.
• W2129404964 countsByYear W21294049642013 @default.
• W2129404964 countsByYear W21294049642014 @default.
• W2129404964 countsByYear W21294049642015 @default.
• W2129404964 countsByYear W21294049642016 @default.
• W2129404964 countsByYear W21294049642017 @default.
• W2129404964 countsByYear W21294049642018 @default.
• W2129404964 countsByYear W21294049642019 @default.
• W2129404964 countsByYear W21294049642020 @default.
• W2129404964 countsByYear W21294049642021 @default.
• W2129404964 countsByYear W21294049642022 @default.
• W2129404964 countsByYear W21294049642023 @default.
• W2129404964 crossrefType "journal-article" @default.
• W2129404964 hasAuthorship W2129404964A5005643972 @default.
• W2129404964 hasAuthorship W2129404964A5015843988 @default.
• W2129404964 hasAuthorship W2129404964A5023620537 @default.
• W2129404964 hasAuthorship W2129404964A5050027407 @default.
• W2129404964 hasAuthorship W2129404964A5065683911 @default.
• W2129404964 hasAuthorship W2129404964A5066301296 @default.
• W2129404964 hasAuthorship W2129404964A5069514816 @default.
• W2129404964 hasBestOaLocation W21294049641 @default.
• W2129404964 hasConcept C126322002 @default.
• W2129404964 hasConcept C131075544 @default.
• W2129404964 hasConcept C134018914 @default.
• W2129404964 hasConcept C160160445 @default.
• W2129404964 hasConcept C170033053 @default.
• W2129404964 hasConcept C181199279 @default.
• W2129404964 hasConcept C185592680 @default.
• W2129404964 hasConcept C2776541429 @default.
• W2129404964 hasConcept C2776886416 @default.
• W2129404964 hasConcept C2777083390 @default.
• W2129404964 hasConcept C55493867 @default.
• W2129404964 hasConcept C71924100 @default.
• W2129404964 hasConceptScore W2129404964C126322002 @default.
• W2129404964 hasConceptScore W2129404964C131075544 @default.
• W2129404964 hasConceptScore W2129404964C134018914 @default.
• W2129404964 hasConceptScore W2129404964C160160445 @default.
• W2129404964 hasConceptScore W2129404964C170033053 @default.
• W2129404964 hasConceptScore W2129404964C181199279 @default.
• W2129404964 hasConceptScore W2129404964C185592680 @default.
• W2129404964 hasConceptScore W2129404964C2776541429 @default.
• W2129404964 hasConceptScore W2129404964C2776886416 @default.
• W2129404964 hasConceptScore W2129404964C2777083390 @default.

• next